Although we did not indicate differences in leptin concentrations in PanNEN patients and management, due to the proven role of leptin in cancerogenesis and pancreatic cancer, further research in more numerous NEN cohorts is required. This evidence concerns the gene LEP and familial pancreatic carcinoma.